Æterna Zentaris to Announce Third Quarter 2009 Financial and Operating
Results on November 11, 2009
QUÉBEC CITY,
Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Investors" section, or by telephone using the following numbers: 877-974-0453, 416-644-3431, or 514-227-8860. A replay of the webcast will also be available on the Company's website for a period of 30 days.
About Æterna Zentaris Inc.
Æterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.
For further information: For further information: Investor Relations: Ginette Vallières, Investor Relations Coordinator, (418) 652-8525, ext. 265, [email protected]; Media Relations: Paul Burroughs, Director of Communications, (418) 652-8525, ext. 406, [email protected]
Share this article